Mirum Pharmaceuticals, Inc. (MIRM) vs Scholar Rock Holding Corporation (SRRK)

Mirum Pharmaceuticals, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. Mirum Pharmaceuticals, Inc. and Scholar Rock Holding Corporation are of similar size ($6.0B and $5.8B). Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against 44.0%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −139.2%) and the higher return on invested capital (0.00% vs −173.0%). Across the 16 metrics below, Scholar Rock Holding Corporation leads on 10 and Mirum Pharmaceuticals, Inc. on 6.

Valuation

Metric MIRM SRRK Biotechnology median
P/E n/m n/m 7.88
P/S 9.20 134.64 11.47
P/B n/m 25.09 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 9.70 128.39 10.73
Earnings yield (16.21%) (7.08%) (28.84%)
Free cash flow yield (4.82%) (4.66%) (23.03%)

Profitability

Metric MIRM SRRK Biotechnology median
Gross margin 81.72% 0.00% 65.16%
Operating margin (134.93%) 0.00% 0.00%
Net margin (139.18%) 0.00% 0.00%
Free cash flow margin (44.29%) 0.00% 0.00%
Return on equity (702.97%) (167.77%) (57.72%)
Return on assets (97.15%) (94.63%) (49.22%)
Return on invested capital (172.96%) 0.00% 0.00%

Growth

Metric MIRM SRRK Biotechnology median
Revenue growth (TTM) 44.02% 213.65% 5.64%
EPS growth (last fiscal year) 74.59% (33.20%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIRM SRRK Biotechnology median
Debt to equity (71.97) 0.77 0.00
Current ratio 2.86 7.02 4.73
Net debt to EBITDA (19.11) 0.69 0.96

Dividend

Metric MIRM SRRK Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MIRM SRRK Biotechnology median
Market cap 5.84b 5.96b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack